Clinical Trial Update: Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Egyptian adults with chronic genotype 4 hepatitis C virus infect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus | Phase 2 | Status: COMPLETED | Results posted: 2014-11-25